Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in SMMT |
---|---|---|---|---|---|---|
Tema Oncology ETF | $60.92M | 0.75% | 4.18% | $2.59M | 0.01% | |
Loncar Cancer Immunotherapy ETF | $6.92M | 0.79% | 2.35% | $165.35K | <0.01% | |
iShares NASDAQ US Biotechnology UCITS ETF | $24.16M | 0.35% | 2.19% | $9.14M | 0.05% | |
Invesco Nasdaq Biotechnology ETF | $37.84M | 0.19% | 2.07% | $750.61K | <0.01% | |
Virtus LifeSci Biotech Clinical Trials ETF | $9.71M | 0.79% | 1.70% | $169.39K | <0.01% | |
SPDR S&P BIOTECH ETF | $4.93B | 0.35% | 1.52% | $75.00M | 0.39% | |
Loncar China BioPharma ETF | $3.74M | 0.79% | 1.35% | $50.29K | <0.01% | |
Invesco NASDAQ Next Generation 100 UCITS ETF AccumGBP | $43.17M | 0.26% | 1.34% | $539.32K | <0.01% | |
BMO EqWgt US Health | $194.07M | 0.39% | 1.31% | $2.73M | 0.01% | |
BMO Equal Weight US Health Care Index ETF | $8.47M | 0.40% | 1.31% | $175.72K | <0.01% |